Abbott (ABT) Tops Q4 EPS by 2c, Updates FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Abbott Reports Second-Quarter 2018 Results
July 18, 2018 7:45 AM EDTABBOTT PARK, Ill., July 18, 2018 /PRNewswire/ --Â Abbott (NYSE: ABT)Â today announced financial results for the second quarter ended June 30, 2018.
Second-quarter worldwide sales of $7.8 billion increased 17.0 percent on a reported basis and 8.0 percent on an organic* basis. Reported diluted EPS from continuing operations under GAAP was $0.40 in the second quarter. Adjusted diluted EPS from continuing operations, which excludes specified items, was $0.73, above Abbott's previous guidance range. Abbott is raising its full-year 2018 EPS guidance range, which continues to reflect strong double-digit growth. Abbott projects full-year... More